THERACLION (ALTHE.PA) Stock Price, Forecast & Analysis
Europe - Euronext Paris - EPA:ALTHE - FR0010120402 - Common Stock
ALTHE.PA Key Statistics, Chart & Performance
The current stock price of ALTHE.PA is 0.608 EUR. In the past month the price decreased by -0.33%. In the past year, price increased by 124.35%.
ALTHE.PA Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to ALTHE.PA. When comparing the yearly performance of all stocks, ALTHE.PA is one of the better performing stocks in the market, outperforming 95.82% of all stocks.
ALTHE.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to ALTHE.PA. Both the profitability and financial health of ALTHE.PA have multiple concerns.
ALTHE.PA Financial Highlights
Over the last trailing twelve months ALTHE.PA reported a non-GAAP Earnings per Share(EPS) of -0.11. The EPS decreased by -16.67% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -45.47% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
ALTHE.PA Forecast & Estimates
ALTHE.PA Ownership
ALTHE.PA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 2M6.DE | MEDTRONIC PLC | 17.22 | 105.98B | ||
| 1SHL.MI | SIEMENS HEALTHINEERS AG | 19.62 | 52.88B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 18.31 | 49.36B | ||
| 1PHIA.MI | KONINKLIJKE PHILIPS NV | 17.36 | 24.74B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 16.47 | 23.48B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 16.69 | 23.78B | ||
| BIM.PA | BIOMERIEUX | 27.05 | 12.36B | ||
| DIA.MI | DIASORIN SPA | 22.23 | 4.12B | ||
| OBCK.DE | OTTOBOCK SE & CO KGAA | 137.02 | 4.12B | ||
| 1AFX.MI | CARL ZEISS MEDITEC AG - BR | 23.24 | 3.55B | ||
| AFX.DE | CARL ZEISS MEDITEC AG - BR | 21.86 | 3.15B | ||
| DRW3.DE | DRAEGERWERK AG - PREF | 13.4 | 1.62B |
Related stock screener links
About ALTHE.PA
Company Profile
Théraclion SA develops, manufactures, and markets oncological medical equipment. The company is headquartered in Malakoff, Ile-De-France and currently employs 33 full-time employees. The company went IPO on 2014-04-25. The firm is a a spin-off of Inserm and EDAPTechomed. The main activity of the Company is developping, manufacturing and marketing echotherapy medical equipments associating therapy by focused ultrasound and monitoring by ultrasound. The firm provides Echopulse, a device for the non-invasive and outpatient treatment of the fibroadenoma of the breast and thyroid nodules.
Company Info
THERACLION
244, avenue Pierre Brossolette
Malakoff ILE-DE-FRANCE FR
Employees: 28
Phone: 33155489070
THERACLION / ALTHE.PA FAQ
What does ALTHE do?
Théraclion SA develops, manufactures, and markets oncological medical equipment. The company is headquartered in Malakoff, Ile-De-France and currently employs 33 full-time employees. The company went IPO on 2014-04-25. The firm is a a spin-off of Inserm and EDAPTechomed. The main activity of the Company is developping, manufacturing and marketing echotherapy medical equipments associating therapy by focused ultrasound and monitoring by ultrasound. The firm provides Echopulse, a device for the non-invasive and outpatient treatment of the fibroadenoma of the breast and thyroid nodules.
What is the current price of ALTHE stock?
The current stock price of ALTHE.PA is 0.608 EUR. The price increased by 1.33% in the last trading session.
Does ALTHE stock pay dividends?
ALTHE.PA does not pay a dividend.
What is the ChartMill rating of THERACLION stock?
ALTHE.PA has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Is THERACLION (ALTHE.PA) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on ALTHE.PA.
What is the employee count for ALTHE stock?
THERACLION (ALTHE.PA) currently has 28 employees.
Can you provide the ownership details for ALTHE stock?
You can find the ownership structure of THERACLION (ALTHE.PA) on the Ownership tab.